The Human Variable 

CDF-Lupus™ reframes systemic lupus erythematosus as a dynamic, multi-system autoimmune pattern rather than a static checklist diagnosis. The framework uses weighted domain scoring to evaluate immune activation, inflammatory signaling, organ involvement, neuroimmune symptoms, hematologic changes, metabolic burden, and environmental or structural modifiers that shape disease recognition over time.

MCAS clinical trials often fail when they ignore hypersensitivity, environmental triggers, flare behavior, and patient instability. CYNAERA’s MCAS clinical trial framework outlines a super-sensitive, flare-aware approach to stabilization, adaptive dosing, endpoint selection, and real-world trial design.

Hashimoto’s thyroiditis is often reduced to abnormal TSH levels, but many patients remain symptomatic despite normal labs. CDF-Hashimoto’s™ reframes diagnosis as a multi-system pattern, integrating immune activity, metabolic dysfunction, neurocognitive symptoms, and environmental triggers. This composite diagnostic fingerprint enables earlier recognition, improved stratification, and a more accurate understanding of autoimmune thyroid disease.